Cite

HARVARD Citation

    Guerrera, G. et al. (2022). Anti-SARS-CoV-2 T-stem cell memory persists in ocrelizumab-treated MS patients. Multiple sclerosis. pp. 1937-1943. [Online]. 
  
Back to record